StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
XCUREXICURE, INC.
stockpulse.co.kr
Nasdaq
$1.02▼ 5.56%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $6.5MShares out 6.4M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

1
  • 9.16Regular26.09.16 23:27
    8-KKey event#●●●

    EXICURE, INC.Bullish

    Exicure, Inc. has received an extension from Nasdaq until December 2, 2026, to regain compliance with the minimum $2.5 million stockholders' equity requirement. The company must demonstrate compliance by this deadline to avoid potential delisting proceedings.…more

    $1.02-5.56%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare

News

GlobeNewswire
  • 9.16Pre-market26.09.16 21:01
    Bullish#●●●

    Exicure Receives Nasdaq Extension Through December 2 To Regain Compliance…more

    Exicure has been granted an extension until December 2 to meet Nasdaq's minimum stockholders' equity requirement. Failure to demonstrate compliance by this deadline could result in the delisting of the company's common stock.…more

    $1.02-5.56%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 8.3Pre-market26.08.03 22:24

    ●●●●●●●● ●●●●● ●●●●●●

    Exicure가 GPCR Therapeutics에 지급해야 할 100만 달러 규모의 임상 마일스톤 대금을 현금 대신 자사주 발행으로 대체합니다. 이번 결정은 현금 보유량을 유지하고 재무적 유연성을 확보하기 위한 조치입니다.…more

    $1.02-5.56%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →